There are several invasive and noninvasive techniques used to diagnose H. pylori infection, each having its advantages and disadvantages. Invasive methods require biopsy samples from the stomach and duodenum and can be tested by various methods such as histology, Rapid urease test (RUT), microbiological culture, and Polymerase chain reaction (PCR), whereas noninvasive tests including stool antigen test, serology, and urea breath test. Objective: To determine the diagnostic accuracy of the Helicobacter pylori fecal antigen test by taking endoscopic biopsy as the gold standard in dyspeptic patients. Materials & Methods: Descriptive, cross-sectional study was conducted from 30th April 2019 to 30th October 2019 in Gastroenterology Unit, Holy Family Hospital, Rawalpindi. A total of 85 patients irrespective of gender aged 18-65 years with symptoms of dyspepsia (epigastric pain, early satiety, postprandial fullness, nausea, or retching) were included. Patients having gall bladder or pancreatic diseases, celiac disease, diabetes mellitus, thyroid disease, ischemic heart disease, chronic liver diseases, HIV, malignancy, alcoholism, pylori infection or treatment, drug PPI or H2 receptors, and pregnant were excluded. H. Pylori on fecal antigen detection and endoscopic biopsy was noted. Results: Fecal antigen detection test found that 42 were True Positive and 04 were False Positive. Among 39, fecal antigen-negative patients, 04 (False Negative) had H. Pylori on endoscopic biopsy whereas 35 (True Negative) had no H. Pylori involvement on endoscopic biopsy (p=0.0001). Overall sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of H. Pylori Fecal antigen detection taking endoscopic biopsy as the gold standard in dyspeptic patients was 91.30%, 89.74%, 91.30%, 89.74%, and 90.59% respectively. Conclusion: The study concluded that the diagnostic accuracy of Helicobacter pylori fecal antigen detection in dyspeptic patients is quite high.